苯基环己基甲胺 | 23459-35-0

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 苯基环己基甲胺
• 英文名称: cyclohexyl(phenyl)methanamine
• 英文别名: α-cyclohexylbenzylamine；cyclohexylphenylmethylamine
• CAS: 23459-35-0
• 化学式: C₁₃H₁₉N
• 分子量: 189.301
• InChiKey: JQCBKIHKSZUZKT-UHFFFAOYSA-N

物化性质

• 沸点：
  140 °C(Press: 10 Torr)
• 密度：
  0.993 g/cm3(Temp: 25 °C)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2921499090

反应信息

• 作为反应物：
  描述：

  苯基环己基甲胺 在 palladium on activated charcoal 氢气 作用下， 以 乙醇 为溶剂， 50.0~190.0 ℃ 、3.03 MPa 条件下， 反应 48.0h， 生成 N-(cyclohexylphenylmethyl)-2-(1H-imidazol-2-yl)acetamide
  参考文献：
  名称：

  与哌克昔林有关的“软药物”衍生物的合成和药理性质。

  摘要：

  为了减少哌克昔林的毒性，合成了一系列基于“软药物”概念并结合酰胺功能的27种环己基烷基胺II。在初步筛选中，对化合物的α-肾上腺素分解活性进行了评估。几种衍生物，尤其是N-（环己基苯基甲基）-2-（环己基甲基氨基）乙酰胺（3），N-（环己基苯基甲基）-2-（全过甲基甲基氨基）乙酰胺（7）和N- [2-（环己基氨基）乙基] -α-环己基苯乙酰胺（23）在大鼠主动脉条中的体外活性范围与哌己昔林相同。然后研究了这三种分子的体外代谢，并将其与哌己昔林进行了比较。研究了在II上引入各种N-芳烷基胺基对α-肾上腺素解活性的影响。

  DOI：

  10.1021/jm00120a007
• 作为产物：
  描述：

  N-(cyclohexyl(phenyl)methyl)formamide 在 盐酸 作用下， 反应 1.0h， 生成 苯基环己基甲胺
  参考文献：
  名称：

  Synthesis and structure–activity relationships of potential anticonvulsants based on 2-piperidinecarboxylic acid and related pharmacophores

  摘要：

  Using N-(2,6-dimethyl)phenyl-2-piperidinecarboxamide (1) and N-(alpha -methylbenzyl)-2-piperidinecarboxamide (2) as structural leads, a variety of analogues were synthesised and evaluated for anticonvulsant activity in the MES test in mice. In the N-benzyl series, introduction of 3-Cl, 4-Cl, 3,4-Cl-2, or 3-CF3 groups on the aromatic ring led to an increase in MES activity. Replacement of the alpha -methyl group by either i-Pr or benzyl groups enhanced MES activity with no increase in neurotoxicity. Substitution on the piperidine ring nitrogen led to a decrease in MES activity and neurotoxicity, while reduction of the amide carbonyl led to a complete loss of activity. Movement of the carboxamide group to either the 3- or 4-positions of the piperidine ring decreased MES activity and neurotoxicity. Incorporation of the piperidine ring into a tetrahydroisoquinoline or diazahydrinone nucleus led to increased neurotoxicity. In the N-(2,6-dimethyl)phenyl series, opening of the piperidine ring between the 1- and 6-positions gave the active norleucine derivative 75 (ED50 = 5.8 mg kg(-1), TD50 = 36.4 mg kg(-1), PI = 6.3). Replacement of the piperidine ring of I by cycloalkane (cyclohexane, cyclopentane, and cyclobutane) resulted in compounds with decreased MES activity and neurotoxicity, whereas replacement of the piperidine ring by a 4-pyridyl group led to a retention of MES activity with a comparable PI. Simplification of the 2-piperidinecarboxamide nucleus of 1 into a glycinecarboxamide nucleus led to about a six-fold decrease in MES activity. The 2,6-dimethylanilides were the most potent compounds in the MES test in each group of compounds evaluated, and compounds 50 and 75 should be useful leads in the development of agents for the treatment of tonic-clonic and partial seizures in man. (C) 2001 Editions scientifiques et medicales Elsevier SAS.

  DOI：

  10.1016/s0223-5234(00)01206-x
• 作为试剂：
  描述：

  环己基苯基甲酮 、 、 氰基硼氢化钠 在 苯基环己基甲胺 作用下， 以 甲醇 为溶剂， 以to give the title compound (clear oil, 1.41 g, 93%)的产率得到苯基环己基甲胺
  参考文献：
  名称：

  INDAZOLE COMPOUNDS AS KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME

  摘要：

  本教学提供由结构式（I）或（I'）所代表的吲唑化合物或其药学上可接受的盐。还描述了制备药物组合物和使用方法，作为蛋白激酶抑制剂，例如TTK蛋白激酶，极化样激酶4（PLK4）和极化激酶，对乳腺癌细胞，结肠癌细胞和卵巢癌细胞具有抗癌活性。

  公开号：

  US20140371202A1

文献信息

• Chemoselective reductive alkylation of ammonia with carbonyl compounds: synthesis of primary and symmetrical secondary amines
  作者：Bruhaspathy Miriyala、Sukanta Bhattacharyya、John S Williamson

  DOI：10.1016/j.tet.2003.12.024

  日期：2004.2

  efficient, general procedure for highly chemoselective reductive mono-alkylation of ammonia with ketones is reported. Treatment of ketones with ammonia in ethanol and titanium(IV) isopropoxide, followed by in situ sodium borohydride reduction, and a straightforward workup afforded primary amines in good to excellent yields. Reductive alkylation of ammonia with aldehydes, on the other hand, afforded the corresponding

  报道了一种高效的通用方法，用于用酮对氨进行高度化学选择性的还原性单烷基化。用乙醇和异丙醇钛（IV）中的氨处理酮，然后原位还原硼氢化钠，并直接进行后处理，得到的伯胺的收率好至极佳。另一方面，氨与醛的还原烷基化选择性地提供了相应的对称仲胺。
• [EN] BICYCLIC HETEROCYCLE DERIVATIVES AND USE THEREOF AS GPR119 MODULATORS<br/>[FR] DÉRIVÉS HÉTÉROCYCLIQUES BICYCLIQUES ET LEUR UTILISATION EN TANT QUE MODULATEURS DE GPR119
  申请人：SCHERING CORP

  公开号：WO2009143049A1

  公开（公告）日：2009-11-26

  The present invention relates to Bicyclic Heterocycle Derivatives of formula (I), compositions comprising a Bicyclic Heterocycle Derivative, and methods of using the Bicyclic Heterocycle Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of GPR1 19 in a patient.

  本发明涉及公式（I）的双环杂环衍生物，包含双环杂环衍生物的组合物，以及使用双环杂环衍生物治疗或预防患者的肥胖、糖尿病、代谢紊乱、心血管疾病或与GPR119活性相关的疾病的方法。
• [EN] KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME<br/>[FR] INHIBITEURS DE KINASES ET PROCÉDÉ DE TRAITEMENT DU CANCER UTILISANT CEUX-CI
  申请人：UNIV HEALTH NETWORK

  公开号：WO2011123937A1

  公开（公告）日：2011-10-13

  The present teachings provide a compound represented by Strutural Formula (I): or a pharmaceutically acceptable salt thereof. Also described are a pharmaceutical composition and method of use thereof.

  本教学提供了一种由结构式(I)表示的化合物，或其药用可接受的盐。还描述了一种药物组合物及其使用方法。
• METHOD FOR PRODUCING NOVEL ORGANOMETALLIC COMPLEX AND AMINE COMPOUND
  申请人：KANTO KAGAKU KABUSHIKI KAISHA

  公开号：US20160060282A1

  公开（公告）日：2016-03-03

  The purpose of the invention is to provide a novel organometallic compound that can be utilized as a catalyst having high generality, high activity, and excellent functional group selectivity. The invention pertains to a novel organometallic compound represented by general formula (1) that catalyzes a reductive amination reaction.

  该发明的目的是提供一种新型有机金属化合物，可用作具有高普适性、高活性和优异官能团选择性的催化剂。该发明涉及一种由一般式（1）表示的新型有机金属化合物，其催化还原胺化反应。
• NOVEL ORGANIC METAL COMPLEX AND PROCESS FOR PREPARING AMINE COMPOUND
  申请人：Watanabe Masahito

  公开号：US20100234596A1

  公开（公告）日：2010-09-16

  [Problem] The present invention aims to provide a novel organometallic compound that can be used as a general-use highly active catalyst with superior selectivity for functional groups. [Means for Solving Problem] The present invention relates to an organometallic compound having a novel specific structure of general formula (1): and to a general-use highly active catalyst used in reductive amination reaction with superior selectivity for functional groups that comprises said organometallic compound, and to a process for preparing amine compounds by reductive amination reaction using said catalyst.

  [问题] 本发明旨在提供一种新型有机金属化合物，可用作具有对官能团具有优越选择性的通用高活性催化剂。 [解决问题的方法] 本发明涉及一种具有通用式（1）的新型特定结构的有机金属化合物： 以及一种通用高活性催化剂，用于还原胺化反应，具有对官能团具有优越选择性，包括所述有机金属化合物，并且涉及使用该催化剂通过还原胺化反应制备胺化合物的方法。